Pneumonia Caused By Severe Acute Respiratory Syndrome Coronavirus 2 — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for pneumonia caused by severe acute respiratory syndrome coronavirus 2. 17 active patents protecting 1 drugs from 1+ originators. First major cliff: 2029. Daily refresh.

1
Approved drugs
17
Active US patents
62/100
Avg vulnerability
$1.2B
Annual revenue covered

Originators in Pneumonia Caused By Severe Acute Respiratory Syndrome Coronavirus 2

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Eli Lilly 17 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating pneumonia caused by severe acute respiratory syndrome coronavirus 2. Each bar = one year. Y-axis scaled to peak year (9 patents).

2
29
6
31
9
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Olumiant
baricitinib
 Eli Lilly 17 62 $1.2B 2029-03-10

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11806555 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
9737469 Olumiant method of use 76 2031-11-02
11806555 Olumiant method of use 76 2031-11-02
11806555 Olumiant method of use 76 2031-11-02
8420629 Olumiant method of use 75 2029-03-10
8420629 Olumiant method of use 75 2029-03-10
9089574 Olumiant method of use 70 2032-11-30
9089574 Olumiant method of use 70 2032-11-30

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8158616 Olumiant composition of matter 4 2032-05-31
8158616 Olumiant composition of matter 4 2032-05-31
8158616 Olumiant composition of matter 12 2032-05-31
9089574 Olumiant method of use 70 2032-11-30
9089574 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30
9089574 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30
11045474 Olumiant method of use 70 2032-11-30
8420629 Olumiant method of use 75 2029-03-10

Related